Sage Therapeutics shares owned by Princeton Global Asset Management
Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by Princeton Global Asset Management
from 13F filings
Historical chart of Princeton Global Asset Management investment in Sage Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Sage Therapeutics held by Princeton Global Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Sage Therapeutics by Princeton Global Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $19k | 1.0k | 18.74 |
2023-12-31 | $22k | 1.0k | 21.67 |
2023-09-30 | $21k | 1.0k | 20.58 |
2023-06-30 | $47k | 1.0k | 47.02 |
2023-03-31 | $42k | 1.0k | 41.96 |
2022-12-31 | $38k | 1.0k | 38.00 |
2022-09-30 | $39k | 1.0k | 39.00 |
2022-06-30 | $32k | 1.0k | 32.00 |
2022-03-31 | $33k | 1.0k | 33.00 |
2021-12-31 | $43k | 1.0k | 43.00 |
2021-09-30 | $44k | 1.0k | 44.00 |
More positions owned by Princeton Global Asset Management
View all positions for Princeton Global Asset Management